8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001558370-25-011820
$ADAPCIK 0001621227operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:30 PM ET
Size
262.3 KB
Accession
0001558370-25-011820
Documents
- 8-Kadap-20250829x8k.htmPrimary
8-K
- EX-10.1adap-20250829xex10d1.htm
EX-10.1
- EX-10.2adap-20250829xex10d2.htm
EX-10.2
- GRAPHICadap-20250829xex10d1001.jpg
GRAPHIC
- GRAPHICadap-20250829xex10d1002.jpg
GRAPHIC
- GRAPHICadap-20250829xex10d1005.jpg
GRAPHIC
- GRAPHICadap-20250829xex10d1006.jpg
GRAPHIC
- EX-101.SCHadap-20250829.xsd
EX-101.SCH
- EX-101.LABadap-20250829_lab.xml
EX-101.LAB
- EX-101.PREadap-20250829_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-011820-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20250829x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:30 PM ET
- Size
- 262.3 KB